How to Minimize the Burden of Fusion with ERAS

<p>Featuring: Michael Y. Wang, MD and Daniel K. Resnick, MD</p> <p><br></p> <p>Disclosures:</p> <p>Resnick, Daniel: Scientific Advisory Board: NIDUS (None).</p> <p>Wang, Michael Y.: Royalties: DePuy Synthes Spine (F); Stock Ownership: ISD (1%), Medical Device Partners (1%); Consulting: Stryker (C), Spineology (C), K2M (C), DePuy Synthes (C); Scientific Advisory Board: Vallum (A).</p> <p>Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+</p>